Benefits
Waist Circumference Reduction
Multiple RCTs show Slimaluma significantly reduces waist circumference vs placebo. Kuriyan 2007 (n=50, 60 days) and subsequent studies. Visceral fat reduction beyond just weight loss.
Appetite Suppression
Traditional use by tribal hunters in India for hunger suppression during long hunting periods. Modern clinical evidence supports appetite control mechanism.
Body Composition Improvements
Reductions in body fat mass, body weight, BMI in clinical trials. Effects modest but consistent.
FDA Letter of No Objection
FDA issued letter of no objection for Slimaluma use in meal replacement products — regulatory acknowledgment of safety.
Comprehensive Safety Assessment
Multiple safety studies including comprehensive toxicology assessments published. Safety profile well-characterized.
Mechanism of action
Hypothalamic Appetite Center Modulation
Theoretical mechanism: pregnane glycosides modulate hypothalamic appetite control centers.
Reduced Food Intake / Caloric Deficit
Appetite suppression leads to reduced caloric intake — foundation for weight management effects.
Citrate Lyase Inhibition
Some research suggests inhibition of citrate lyase — enzyme involved in fatty acid synthesis.
Standardized Pregnane Glycoside Profile
Saanroo standardization ensures consistent active compound delivery.
Clinical trials
RCT of Slimaluma (1 g/day) vs placebo in 50 overweight Indian adults for 60 days.
50 overweight adults.
Significant reduction in waist circumference and waist:hip ratio vs placebo. Modest body weight effects.
Comprehensive toxicology studies of Slimaluma for regulatory submissions.
Animal toxicology and human safety.
Well-tolerated at supplemental doses; no significant adverse effects in long-term safety studies.